What amount sold does LexaGene Life Sciences RD Investors, LLC report in Form D filings?

The latest linked filings report $0 sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was LexaGene Life Sciences RD Investors, LLC's most recent SEC filing?

LexaGene Life Sciences RD Investors, LLC's most recent Form D filing was on 2024-03-20.

What type of securities does LexaGene Life Sciences RD Investors, LLC offer?

LexaGene Life Sciences RD Investors, LLC's SEC Form D filings indicate equity offerings.

LexaGene Life Sciences RD Investors, LLC

CIK: 0002016398·Other Health Care·DALLAS, TX·Limited Liability Company·Founded 2023

Reported Sold

Total Filings

Identified Offerings

Last Filed

Mar 20, 2024

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Other Health Care industry

SEC EDGAR

Offering filing timeline

Mar 20, 2024Form D — New notice

Reported sold: $0 · Target: $10,000,000

Rule 506(c)·0 investors

Fundraising Profile

Exemptions

Rule 506(c)

Investors in latest filing

Revenue Range

Not Applicable

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Curtis R Boisfontaine Jr

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Mar 20, 2024	New	$10,000,000	$0	0

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Tenora Studios, LLC

Other Health Care

Offering target: $10,000,000

Filed Oct 30, 2026